Researchers increase understanding of gene's potentially protective role in Parkinson's

February 7, 2012

Treatments for Parkinson's disease, estimated to affect 1 million Americans, have yet to prove effective in slowing the progression of the debilitating disease.

However, University of Alabama researchers have identified how a specific gene protects dopamine-producing neurons from dying in both animal models and in cultures of human neurons, according to a scientific article publishing in the Feb. 8 edition of The Journal of Neuroscience.

This increased understanding of the gene's neuro-protective capability is, the researchers said, another step toward the potential development of a new drug treatment.

"This gene represents a previously unexplored protein for Parkinson's disease," said Dr. Guy Caldwell, professor of at The University of Alabama and a co-author of the article.

The gene, known as VPS41, was one of five that UA scientists showed in 2008 had protective capabilities against a hallmark trait of Parkinson's, the age-associated loss of .

The latest announcement reflects the better understanding since gained of how the gene functions.

The latest UA research was primarily funded by the Michael J. Fox Foundation for Parkinson's Research. The scientific journal, published by the Society of Neuroscience, is the largest weekly journal dedicated to neuroscience discovery.

The researchers also found that specific, and rare changes in – changes sometimes also evident in non-Parkinson's patients – appear to impact how VPS41 functions.

"Mutations like these may represent previously unreported susceptibility factors for Parkinson's disease," Caldwell said.

The article's lead author is Dr. Adam Harrington, who earned his doctoral degree from UA in December 2011 while working in the Caldwell Lab. The additional UA co-author is Dr. Kim Caldwell, associate professor of biological sciences. Dr. Talene Yacoubian, a physician, and Sunny Slone, both of the University of Alabama at Birmingham, are also co-authors.

The researchers used both specific strains of tiny nematode worms as animal models for the work along with the human cultures. The genetically engineered worms contain a human protein, alpha-synuclein within their cells. Scientists have learned that people with too many copies of the code for alpha-synuclein within their DNA will contract Parkinson's.

Extra copies of alpha-synuclein can lead to repeated protein misfolding and the death of the dopamine-producing neurons in the brain. In Parkinson's patients, the death of these neurons leads to rigid and tremoring limbs, difficulty in movement and impaired reflexes.

"The main advance here is that we have mechanistically defined how VPS41 appears to convey its protective capacity to neurons – not only in worms, but also in human dopamine-producing neuron cultures," said Caldwell.

The next phase in this research involves translating these findings into potential therapies.

"The obstacles of finding any disease-modifying therapy are diminished once protective mechanisms, like this one, become revealed and better defined," said Caldwell.

Related Stories

Recommended for you

Surprising similarity in fly and mouse motion vision

July 29, 2015

At first glance, the eyes of mammals and those of insects do not seem to have much in common. However, a comparison of the neural circuits for detecting motion shows surprising parallels between flies and mice. Scientists ...

Research grasps how the brain plans gripping motion

July 28, 2015

With the results of a new study, neuroscientists have a firmer grasp on the way the brain formulates commands for the hand to grip an object. The advance could lead to improvements in future brain-computer interfaces that ...

New research rethinks how we grab and hold onto objects

July 28, 2015

It's been a long day. You open your fridge and grab a nice, cold beer. A pretty simple task, right? Wrong. While you're debating between an IPA and a lager, your nervous system is calculating a complex problem: how hard to ...

It don't mean a thing if the brain ain't got that swing

July 27, 2015

Like Duke Ellington's 1931 jazz standard, the human brain improvises while its rhythm section keeps up a steady beat. But when it comes to taking on intellectually challenging tasks, groups of neurons tune in to one another ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.